New psychoactive substances in prison. Results from an EMCDDA trendspotter study
Αποθηκεύτηκε σε:
European Monitoring Centre for Drugs and Drug Addiction, New psychoactive substances in prison. Results from an EMCDDA trendspotter study. Luxemburgo, Publications Office of the European Union, 2018, 20 p.
Ref.
534581
Τοποθεσία:
SIIS Archivo
Palabras clave:
Exclusión social, Prisión, Drogodependencias, Drogas de síntesis, Concepto, Clasificación, Patrones de consumo, Efectos, Salud mental, Características, Evaluación, Europa
Exclusión social, Prisión, Drogodependencias, Drogas de síntesis, Concepto, Clasificación, Patrones de consumo, Efectos, Salud mental, Características, Evaluación, Europa
Παρόμοια τεκμήρια: New psychoactive substances in prison. Results from an EMCDDA trendspotter study
- High-risk drug use and new psychoactive substances. Results from an EMCDDA trendspotter study
- Recent changes in Europe's cocaine market. Results from an EMCDDA trendspotter study
- Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons. Results from an EMCDDA trendspotter study
- Recent changes in Europe's MDMA/ecstasy market. Results from an EMCDDA trendspotter study
- EMCDDA-Europol Joint Report on a new psychoactive substance: 5-(2-aminopropyl)indole. In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances
- New psychoactive substances in Europe. An update from the EU Early Warning System